Ryota Morinaga Takashi Kawahara Jun-Ichi Teranishi Makoto Chuma Koji Izumi Yasuhide Miyoshi Masahiro Yao Masako Otani Hiroshi Miyamoto Hiroji Uemura
10.1002/iju5.12035
IJU Case Rep
2018 Dec 28;2(1):43-46.
raf papillary renal cell carcinoma second‐line therapy sorafenib
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/32743370/
Case Reports
PMC7292102
32743370
Successful treatment with sorafenib for sunitinib-refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
2018